Astellas Pharma Awards Accenture 8-Year Contract to Standardize Global IT Operations

Accenture ACN has signed an eight-year application outsourcing agreement with Astellas Pharma Inc. (TSE:4503, “Astellas”). As part of the contract, Accenture will deliver application development and maintenance services to the leading pharmaceutical company, which researches, develops and manufactures prescription drugs. Accenture will help modernize and standardize Astellas' core business systems, such as accounting, production management, purchasing and supply chain management in its Japan, North America and European regions. Accenture will leverage its Global Delivery Network locations in India, China and Brazil to support the engagement. Astellas' objective for the engagement is to prepare a foundation for accelerated globalization of its business. See full press release
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsGuidanceContractsManagementGlobal
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!